Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex dives 850 pts, Nifty slips below 24,200 amid oil shock and weak global cues
The equity benchmark indices Sensex and Nifty tumbled on Thursday, extending losses for a second straight session. Firm crude oil prices and ongoing geopolitical tensions rattled sentiment. Brent crude surged for the fourth consecutive day to around $103 per barrel amid uncertainty over US-Iran talks and fresh concerns around the Strait of Hormuz. Weak Asian cues and persistent foreign fund outflows deepened the sell-off. The Nifty slipped below the 24,200 mark, dragged by auto, PSU banks and consumer durables stocks, while pharma and healthcare shares saw selective buying. Investors stayed cautious, closely tracking the ongoing Q4 earnings season for further triggers.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.

Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.
Sensex crash over 2,235 in early trade; VIX surges 20.82%
The Nifty traded below the 23,750 mark. All sectoral indices on the NSE were traded in the red, with PSU bank, auto and healthcare shares declining the most.

Live: Nifty logs second weekly loss; rupee rebounds 80 paise | Closing Bell
Indian equities traded lower on Friday afternoon as weakness in metal and information technology stocks outweighed gains in select financial, healthcare and consumer names. At 2:18 pm, the Sensex was down 299.98 points or 0.40 percent at 74,060.03, while the Nifty slipped 110.15 points or 0.47 percent to 23,306.40. Market breadth remained weak, with 2,070 stocks declining against 1,720 advances. The Nifty Metal index dropped nearly 2 percent and Nifty IT fell over 1 percent, while broader markets also underperformed. However, the Nifty Media index surged more than 2 percent and realty stocks traded higher, offering some support. Catch Lovish Darad in conversation with Market Experts.

Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules
The broader Nifty Pharma index also traded lower, falling 0.47% to 24,220.10.

Stellar Wealth Partners India Fund acquires 0.87% stake in Sakar Healthcare, Zerodha Broking buys Rs 93 crore worth of Nazara Tech shares
Shares of Sakar Healthcare Limited may have reacted positively to the bulk deal, soaring 16.16 percent to end at a record closing high of Rs 696.7 amid strong volumes on the National Stock Exchange. Strong buying interest was also seen in Nazara Technologies Limited as its shares surged 12.76 percent to Rs 299.95.

SBI MF, Nippon India MF buy Rs 272 crore worth Pine Labs shares; ICICI Pru MF acquire 1.5% stake in Indoco Remedies
SBI Mutual Fund through SBI Midcap Fund held 5.24 percent stake in Pine Labs, the point of sale and payment systems provider, as of March 2026.